91ÖÆƬ³§

Intended for Healthcare Professionals

AmnioRepair® Allograft

Amniotic Membrane Allograft

AmnioRepair Allograft Flyer
OverviewKey Data PointsSystem FeaturesSpecificationsEducationPatient ResourcesAdditional Information

Providing a protective cover

91ÖÆƬ³§ is your trusted partnerÌýproviding you with innovative solutions for treating wounds and tendonÌýraptures. AmnioRepairÌýAllograftÌýdeliversÌýa lyophilized placental membrane allograft that is aseptically processed to preserve the native extracellular matrix and endogenous proteins.

Anatomy

  • ¸é±ð²õ³Ù´Ç°ù²¹³Ù¾±±¹±ðÌý°Õ³ó±ð°ù²¹±è¾±±ð²õ

Procedure

  • Wound Covering

AmnioRepair contains 3 times more Epidermal growth factor (EGF) and 6 times more basic fibroblast growth factor (bFGF) than a competitive allograft.1

The proprietary lyophilization process used to produce AmnioRepair retained

4.5x

more of the structural extracellular matrix (ECM) hyaluronic acid than a competitive allograft.1

System Features

AmnioRepair is indicated for use as a biological barrier or wound cover. Each allograftÌýis restricted to homologous use for the procedure on a single occasion by aÌýlicensedÌýphysician or surgeon.Ìý

AmnioRepair uses a proprietary freeze-drying solution during lyophilization to preserve protein structures and maintain bioactive capabilities of important wound healing elements such as EGF and bFGF.

System Features

Growth Factor Level

AmnioRepairÌýis a placental allograft processed with proprietary methods to maximize theÌýretentionÌýand preservation of growth factors and other extracellular matrix (ECM) components. AmnioRepair is processed via freeze drying (lyophilization) rather than oven drying to remove water and stabilize forÌýlong-term room temperature storage.ÌýLyophilizationÌýavoids the damage or destruction heat can have on sensitive molecules of the tissue product like specific growthÌýfactors.Ìý

This proprietary process results in more growth factors persevered in AmnioRepair compared to a competitive allograft.1ÌýAmnioRepairÌýcontains 3 times more epidermal growth factor (EGF) and 6 time more basic fibroblast growth factor (bFGF) than a competitive allograft.1

Simple Handling

Simple handling characteristics and easy to identify orientationÌýdesigned toÌýallow for ease of application.Ìý

  • Bilayer composition of human amnion and chorion

  • Room temperature storage

  • User-friendly texture, flexibility and thicknessÌý

  • No rehydration required

Specifications

Education

Literature

AmnioRepair AllograftÌýFlyer

AmnioRepair Allograft Product Brochure

Biologics U.S. Product PortfolioÌý

AmnioRepair® Diabetic Foot Ulcer Case Studies

Composition and Cellular Effects of AmnioRepair® and EpiFix®

White Paper

Patient Resources

Patient Access Solutions

Additional Information

Legal Disclaimer

All content herein is protected by copyright, trademarks and other intellectual property rights, as applicable, owned by or licensed to 91ÖÆƬ³§ or its affiliates unless otherwise indicated, and must not be redistributed, duplicated or disclosed, in whole or in part, without the express written consent of 91ÖÆƬ³§.  Ìý

This material is intended for health care professionals. Distribution to any other recipient is prohibited.Ìý

For product information, including indications, contraindications, warnings, precautions, potential adverse effects and patient counseling information, see theÌýinstructions for use or contact your local representative; search this website for additional product information.ÌýTo obtain a copy of the current Instructions for Use (IFU) for full prescribing and risk information, please visit .ÌýFor product related questions, please call 1-800-348-2759.Ìý